The impact of insulin sensitisers on lung function in patients with chronic obstructive pulmonary disease and diabetes

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 3, 2010, Pages 362-367

  Kim, H J ^a   Lee, J Y ^b   Jung, H S ^b   Kim, D K ^c   Lee, S M ^b   Yim, J J ^b   Yang, S C ^b   Yoo, C G ^b   Chung, H S ^c   Kim, Y W ^b   Han, S K ^b   Shim, Y S ^b   Lee, Chang Hoon ^c  

^a Konkuk University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

Author keywords

Chronic obstructive pulmonary disease; Diabetes; Insulin resistance; Insulin sensitiser; Lung function

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLUCOCORTICOID; INSULIN; INSULIN SENSITIZING AGENT; METFORMIN;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALER; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPIROMETRY;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SPIROMETRY; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 77949520140     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Walter R E, Beiser A, Givelber R J, et al. Association between glycemic state and lung function: the Framingham Heart Study. Am J Respir Crit Care Med 2003; 167: 911-916.
2. Yeh H C, Punjabi N M, Wang N Y, et al. Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes Care 2005; 28: 1472-1479.
3. Lawlor D A, Ebrahim S, Smith G D. Associations of measures of lung function with insulin resistance and Type 2 diabetes: fi ndings from the British Women's Heart and Health Study. Diabetologia 2004; 47: 195-203.
4. Lazarus R, Gore C J, Booth M, et al. Effects of body composition and fat distribution on ventilatory function in adults. Am J Clin Nutr 1998; 68: 35-41.
5. Barzilay J I, Cotsonis G A, Walston J, et al. Insulin resistance is associated with decreased quadriceps muscle strength in nondiabetic adults aged > or = 70 years. Diabetes Care 2009; 32: 736-738.
6. Lazarus R, Sparrow D, Weiss S T. Handgrip strength and insulin levels: cross-sectional and prospective associations in the Normative Aging Study. Metabolism 1997; 46: 1266-1269.
7. Lazarus R, Sparrow D, Weiss S T. Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the Normative Aging Study. Eur Respir J 1998; 12: 641-645.
8. Corpeleijn E, Mensink M, Kooi M E, et al. Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss. Obesity (Silver Spring) 2008; 16: 1025-1032.
9. Frye R L, August P, Brooks M M, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009; 360: 2503-2515.
10. Shepherd P R, Kahn B B. Glucose transporters and insulin action - implications for insulin resistance and diabetes mellitus. N Engl J Med 1999; 341: 248-257.
11. Barnes P J. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 269-280.
12. Dandona P, Aljada A, Chaudhuri A, et al. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes and infl ammation. Circulation 2005; 111: 1448-1454.
13. Barker D J, Godfrey K M, Fall C, et al. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 1991; 303: 671-675.
14. Lawlor D A, Ebrahim S, Davey Smith G. Association of birth weight with adult lung function: fi ndings from the British Women's Heart and Health Study and a meta-analysis. Thorax 2005; 60: 851-858.
15. Forsen T, Eriksson J, Tuomilehto J, et al. The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med 2000; 133: 176-182.
16. Braun B, Rock P B, Zamudio S, et al. Women at altitude: shortterm exposure to hypoxia and/or alpha(1)-adrenergic blockade reduces insulin sensitivity. J Appl Physiol 2001; 91: 623-631.
17. Pollard A J, Barry P W, Mason N P, et al. Hypoxia, hypocapnia and spirometry at altitude. Clin Sci (Lond) 1997; 92: 593-598.
18. Krampl E, Kametas N A, Nowotny P, et al. Glucose metabolism in pregnancy at high altitude. Diabetes Care 2001; 24: 817-822.
19. Lee W C, Chen J J, Hunt D D, et al. Effects of hiking at altitude on body composition and insulin sensitivity in recovering drug addicts. Prev Med 2004; 39: 681-688.
20. Sauerwein H P, Schols A M. Glucose metabolism in chronic lung disease. Clin Nutr 2002; 21: 367-371.
21. Anthonisen N R, Skeans M A, Wise R A, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005; 142: 233-239.
22. Calverley P M, Anderson J A, Celli B, et al. Salmeterol and fl uticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-789.
23. Celli B R, Thomas N E, Anderson J A, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008; 178: 332-338.
24. Tashkin D P, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 1543-1554.
25. Donohue J F. Combination therapy for chronic obstructive pulmonary disease: clinical aspects. Proc Am Thorac Soc 2005; 2: 272-281; discussion 290-291.
26. Hanania N A, Ambrosino N, Calverley P, et al. Treatments for COPD. Respir Med 2005; 99 (Suppl B): S28-S40.
27. Bland J M, Altman D G. Regression towards the mean. BMJ 1994; 308: 1499.
28. Bland J M, Altman D G. Some examples of regression towards the mean. BMJ 1994; 309: 780.
29. Suissa S. Lung function decline in COPD trials: bias from regression to the mean. Eur Respir J 2008; 32: 829-831.